Quetiapine or haloperidol as monotherapy for bipolar mania—a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

European Neuropsychopharmacology - Tập 15 Số 5 - Trang 573-585 - 2005
Roger S. McIntyre1, Martin Brecher2, Björn Paulsson3, Karin Huizar3, Jamie Mullen2
1Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada
2AstraZeneca Pharmaceuticals, Wilmington, DE, USA
3Clinical R&D, AstraZeneca Pharmaceuticals, Södertälje, Sweden

Tóm tắt

Từ khóa


Tài liệu tham khảo

Altamura, 2003, Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study, J. Affect Disord., 76, 267, 10.1016/S0165-0327(02)00075-7

2002, Practice guideline for the treatment of patients with bipolar disorder, Am. J. Psychiatry, 159, 1

Arvanitis, 1997, Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group, Biol. Psychiatry, 42, 233, 10.1016/S0006-3223(97)00190-X

Barnes, 1989, A rating scale for drug-induced akathisia, Br. J. Psychiatry, 154, 672, 10.1192/bjp.154.5.672

Buckley, 2004, Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia, Schizophr. Res., 66, 143, 10.1016/j.schres.2003.06.001

CGI: Clinical Global Impressions, 1970. In: Guy W. and Bonato R. (Eds.) Manual for the ECDEU Assessment Battery. National Institute of Mental Health, Chevy Chase, MD, pp. 12-1 to 12-6.

Chisholm, 2001, Clinical response to quetiapine add-on for treatment of refractory bipolar disorder

Copolov, 2000, A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, ‘Seroquel’) and haloperidol in schizophrenia, Psychol. Med., 30, 95, 10.1017/S0033291799001476

DelBello, 2002, A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania, J. Am. Acad. Child Adolesc. Psych., 41, 1216, 10.1097/00004583-200210000-00011

Dittmann, 2002, Results of the naturalistic follow-up study after 2.5 years of follow-up in the German centres, Neuropsychobiology, 46, 2, 10.1159/000068018

Dunayevich, 2001

Emsley, 2000, A comparison of the effects of quetiapine (‘Seroquel’) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group, Int. Clin. Psychopharmacol., 15, 121, 10.1097/00004850-200015030-00001

Endicott, 1976, The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance, Arch. Gen. Psychiatry, 33, 766, 10.1001/archpsyc.1976.01770060086012

Ghaemi, 2003, Effects of newer vs. older antidepressants in bipolar depression

Goodwin, 2003, Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology, J. Psychopharmacol., 17, 149, 10.1177/0269881103017002003

Grunze, 2003, Guidelines for the biological treatment of bipolar disorders: Part II. Treatment of mania, World J. Biol. Psychiatry, 4, 5, 10.3109/15622970309167904

Hirschfeld, 2004, Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial, Am. J. Psychiatry, 161, 1057, 10.1176/appi.ajp.161.6.1057

Kasper, 2001, Quetiapine: efficacy and tolerability in schizophrenia, Eur. Neuropsychopharmacol., 11, S405, 10.1016/S0924-977X(01)00111-0

Kasper, 2004, Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia, Int. Clin. Psychopharmacol., 19, 281, 10.1097/01.yic.0000138822.62874.fd

Kay, 1987, The Positive and Negative Syndrome Scale (PANSS) for schizophrenia, Schizophr. Bull., 13, 261, 10.1093/schbul/13.2.261

Keck, 1998, 12-Month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode, Am. J. Psychiatry, 155, 646, 10.1176/ajp.155.5.646

Keck, 2003, Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial, Am. J. Psychiatry, 160, 741, 10.1176/appi.ajp.160.4.741

McElroy, 1996, A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania, J. Clin. Psychiatry, 57, 142

Montgomery, 1979, A new depression scale designed to be sensitive to change, Br. J. Psychiatry, 134, 382, 10.1192/bjp.134.4.382

Mullen, 2003, Quetiapine in combination with mood stabilizer for the treatment of acute mania associated with bipolar disorder (abstract P140), Bipolar Disord., 5, 70

Pae, 2004, Switching to quetiapine in patients with acute mania who were intolerant to risperidone, Hum. Psychopharmacol., 19, 47, 10.1002/hup.549

Sachs, 2002, Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety, Am. J. Psychiatry, 159, 1146, 10.1176/appi.ajp.159.7.1146

Sachs, 2004, Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study, Bipolar Disord., 6, 213, 10.1111/j.1399-5618.2004.00115.x

Sajatovic, 2001, Quetiapine alone and added to a mood stabilizer for serious mood disorders, J. Clin. Psychiatry, 62, 728, 10.4088/JCP.v62n0911

Segal, 1998, Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial, Clin. Neuropharmacol., 21, 176

Shi, 2002, Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status, Int. Clin. Psychopharmacol., 17, 227, 10.1097/00004850-200209000-00003

Simpson, 1970, A rating scale for extrapyramidal side effects, Acta Psychiatr. Scand., Suppl., 212, 11, 10.1111/j.1600-0447.1970.tb02066.x

Small, 1995, Lithium combined with carbamazepine or haloperidol in the treatment of mania, Psychopharmacol. Bull., 31, 265

Small, 1997, Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group, Arch. Gen. Psychiatry, 54, 549, 10.1001/archpsyc.1997.01830180067009

Spearing, 1997, Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI–BP, Psychiatry Res., 73, 159, 10.1016/S0165-1781(97)00123-6

Tohen, 1999, Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group, Am. J. Psychiatry, 156, 702, 10.1176/ajp.156.5.702

Tohen, 2000, Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group, Arch. Gen. Psychiatry, 57, 841, 10.1001/archpsyc.57.9.841

Tohen, 2002, Olanzapine versus divalproex in the treatment of acute mania, Am. J. Psychiatry, 159, 1011, 10.1176/appi.ajp.159.6.1011

Vieta, 2002, Quetiapine in the treatment of rapid cycling bipolar disorder, Bipolar Disord., 4, 335, 10.1034/j.1399-5618.2002.01204.x

White, 1997, Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group, Psychopathology, 30, 263, 10.1159/000285058

Yatham, 2003, Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial, Br. J. Psychiatry, 182, 141, 10.1192/bjp.182.2.141

Young, 1978, A rating scale for mania: reliability, validity and sensitivity, Br. J. Psychiatry, 133, 429, 10.1192/bjp.133.5.429

Zarate, 2000, Clinical predictors of acute response with quetiapine in psychotic mood disorders, J. Clin. Psychiatry, 61, 185, 10.4088/JCP.v61n0307